How did Vertex's revenue cost dynamics evolve throughout 2024?

Vertex Pharmaceuticals experienced a significant increase in total revenue, reaching $666.78 million by the end of 2024, compared to $240.65 million in cost of goods sold, indicating a robust financial performance and efficient management of production costs.